Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Hugh Myrick |
Documentos disponibles escritos por este autor (3)
Refinar búsqueda
Diagnosis and treatment of co-occurring affective disorders and substance use disorders / Hugh Myrick en Psychiatric Clinics of North America, Año 2004 - Vol. 27 No. 4 (Diciembre)
[artículo]
Título : Diagnosis and treatment of co-occurring affective disorders and substance use disorders Tipo de documento: texto impreso Autores: Hugh Myrick, Autor ; Jeff Cluver, Autor Fecha de publicación: 2020 Artículo en la página: pp. 649-659 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos del estado de ánimo, Trastornos relacionados con sustancias. Resumen: There is growing interest in the co-occurrence of mood and substance use disorders. It is clear that co-occurrence of these disorders is common and has an impact on prognosis and course of both disorders. The diagnostic issues at the interface of substance or alcohol use disorders and affective illnesses are particularly difficult because of the substantial symptom overlap between substance intoxication and withdrawal and symptoms of affective disorders. Link: ./index.php?lvl=notice_display&id=24694
in Psychiatric Clinics of North America > Año 2004 - Vol. 27 No. 4 (Diciembre) . - pp. 649-659[artículo] Diagnosis and treatment of co-occurring affective disorders and substance use disorders [texto impreso] / Hugh Myrick, Autor ; Jeff Cluver, Autor . - 2020 . - pp. 649-659.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2004 - Vol. 27 No. 4 (Diciembre) . - pp. 649-659
Palabras clave: Trastornos del estado de ánimo, Trastornos relacionados con sustancias. Resumen: There is growing interest in the co-occurrence of mood and substance use disorders. It is clear that co-occurrence of these disorders is common and has an impact on prognosis and course of both disorders. The diagnostic issues at the interface of substance or alcohol use disorders and affective illnesses are particularly difficult because of the substantial symptom overlap between substance intoxication and withdrawal and symptoms of affective disorders. Link: ./index.php?lvl=notice_display&id=24694 Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence / Raymond F. Anton en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 4 (Agosto)
[artículo]
Título : Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence : Relationship to alcohol withdrawal symptoms Tipo de documento: texto impreso Autores: Raymond F. Anton, Autor ; Hugh Myrick, Autor ; Alicia M. Baros, Autor Fecha de publicación: 2022 Artículo en la página: pp. 334-342 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Tratamiento, Flumazenil, Gabapentina, Abstinencia alcohólica Resumen: Improved treatment of alcohol dependence is a high priority, including defining subtypes that might respond differently. We evaluated a medication combination of intravenous flumazenil (FMZ) and oral gabapentin (GBP) in alcoholics who did and did not exhibit pretreatment alcohol withdrawal (AW) symptoms. Link: ./index.php?lvl=notice_display&id=29494
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 4 (Agosto) . - pp. 334-342[artículo] Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence : Relationship to alcohol withdrawal symptoms [texto impreso] / Raymond F. Anton, Autor ; Hugh Myrick, Autor ; Alicia M. Baros, Autor . - 2022 . - pp. 334-342.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 4 (Agosto) . - pp. 334-342
Palabras clave: Alcoholismo, Tratamiento, Flumazenil, Gabapentina, Abstinencia alcohólica Resumen: Improved treatment of alcohol dependence is a high priority, including defining subtypes that might respond differently. We evaluated a medication combination of intravenous flumazenil (FMZ) and oral gabapentin (GBP) in alcoholics who did and did not exhibit pretreatment alcohol withdrawal (AW) symptoms. Link: ./index.php?lvl=notice_display&id=29494 The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics / Hugh Myrick en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 4 (Agosto)
[artículo]
Título : The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics Tipo de documento: texto impreso Autores: Hugh Myrick, Autor ; Xingbao Li, Autor ; Patrick K. Randall, Autor Fecha de publicación: 2022 Artículo en la página: pp. 365-372 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Neuroimagen, Alcoholismo, Craving, Aripiprazol Resumen: Because the effects of alcohol and its environmental cues on brain dopamine have been implicated in the maintenance of heavy drinking, drugs that modify dopamine might be useful in reducing drinking or promoting abstinence. The goal of the current study was to use an established brain imaging paradigm to explore the effect of aripiprazole (final dose 15 mg over a 14-day period), a dopamine stabilizer medication, on alcohol cue-induced brain activation and drinking in alcoholics. Link: ./index.php?lvl=notice_display&id=29435
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 4 (Agosto) . - pp. 365-372[artículo] The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics [texto impreso] / Hugh Myrick, Autor ; Xingbao Li, Autor ; Patrick K. Randall, Autor . - 2022 . - pp. 365-372.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 4 (Agosto) . - pp. 365-372
Palabras clave: Neuroimagen, Alcoholismo, Craving, Aripiprazol Resumen: Because the effects of alcohol and its environmental cues on brain dopamine have been implicated in the maintenance of heavy drinking, drugs that modify dopamine might be useful in reducing drinking or promoting abstinence. The goal of the current study was to use an established brain imaging paradigm to explore the effect of aripiprazole (final dose 15 mg over a 14-day period), a dopamine stabilizer medication, on alcohol cue-induced brain activation and drinking in alcoholics. Link: ./index.php?lvl=notice_display&id=29435